Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.
Original languageUnknown
Pages (from-to)15-7
JournalBiodrugs
Volume24 Suppl 1
Issue numberNA
DOIs
Publication statusPublished - 1 Jan 2010

Cite this

@article{35414c22b4d741c4bbaabef21aaead07,
title = "Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.",
abstract = "Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.",
author = "Calado, {Joaquim Fernando Tomaz Rodrigues Moita}",
year = "2010",
month = "1",
day = "1",
doi = "10.2165/11586250-000000000-00000",
language = "Unknown",
volume = "24 Suppl 1",
pages = "15--7",
journal = "Biodrugs",
issn = "1173-8804",
publisher = "Adis International Limited",
number = "NA",

}

Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab. / Calado, Joaquim Fernando Tomaz Rodrigues Moita.

In: Biodrugs, Vol. 24 Suppl 1, No. NA, 01.01.2010, p. 15-7.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.

AU - Calado, Joaquim Fernando Tomaz Rodrigues Moita

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.

AB - Systemic AA amyloidosis is a serious complication of many chronic inflammatory disorders. Its association with Crohn's disease implies that the inflammatory burden is high enough for amyloid fibrils to form deposits in tissues. A case is presented in which this complication occurred while the patient was clinically well, with biological and endoscopic markers showing an inactive or mildly active disease under anti-tumor necrosis factor alpha therapy.

U2 - 10.2165/11586250-000000000-00000

DO - 10.2165/11586250-000000000-00000

M3 - Article

VL - 24 Suppl 1

SP - 15

EP - 17

JO - Biodrugs

JF - Biodrugs

SN - 1173-8804

IS - NA

ER -